197 related articles for article (PubMed ID: 37125313)
1. Stage-specific therapy for hypertrophic cardiomyopathy.
Argirò A; Zampieri M; Marchi A; Cappelli F; Del Franco A; Mazzoni C; Cecchi F; Olivotto I
Eur Heart J Suppl; 2023 May; 25(Suppl C):C155-C161. PubMed ID: 37125313
[TBL] [Abstract][Full Text] [Related]
2. Management of hypertrophic cardiomyopathy in children.
Seggewiss H; Rigopoulos A
Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
[TBL] [Abstract][Full Text] [Related]
3. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
[TBL] [Abstract][Full Text] [Related]
4. Management of hypertrophic cardiomyopathy.
Enriquez AD; Goldman ME
Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy: a systematic review.
Maron BJ
JAMA; 2002 Mar; 287(10):1308-20. PubMed ID: 11886323
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.
Packard E; de Feria A; Peshin S; Reza N; Owens AT
Cardiol Ther; 2022 Dec; 11(4):491-507. PubMed ID: 36243823
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Marian AJ; Braunwald E
Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy: genetics and clinical perspectives.
Wolf CM
Cardiovasc Diagn Ther; 2019 Oct; 9(Suppl 2):S388-S415. PubMed ID: 31737545
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy.
Antunes MO; Scudeler TL
Int J Cardiol Heart Vasc; 2020 Apr; 27():100503. PubMed ID: 32309534
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
15. Advances in medical treatment of hypertrophic cardiomyopathy.
Hamada M; Ikeda S; Shigematsu Y
J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
[TBL] [Abstract][Full Text] [Related]
16. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
17. Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
Andries G; Yandrapalli S; Naidu SS; Panza JA
Cardiol Rev; 2018; 26(5):239-244. PubMed ID: 29746257
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
Ostman-Smith I
Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
